Hepatothermic therapy of obesity: rationale and an inventory of resources
- 30 September 2001
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 57 (3) , 324-336
- https://doi.org/10.1054/mehy.2000.1322
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Modulation of Insulin Secretion and Glycemia by Selective Inhibition of Cyclic AMP Phosphodiesterase IIIBiochemical and Biophysical Research Communications, 1997
- Dehydroepiandrosterone and Body FatObesity Research, 1995
- Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled StudyThe Journal of Clinical Pharmacology, 1993
- Plasma amino acids and the insulin/glucagon ratio as an explanation for the dietary protein modulation of atherosclerosisMedical Hypotheses, 1991
- Co‐Enzyme Q10: A New Drug for Cardiovascular DiseaseThe Journal of Clinical Pharmacology, 1990
- Inhibition of rat liver acetyl-CoA carboxylase by β,β′-tetramethyl-substituted hexadecanedioic acid (MEDICA 16)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK miceLife Sciences, 1988
- Thyroxine-induced changes in rat liver mitochondrial ubiquinoneBiochemical and Biophysical Research Communications, 1986
- The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Orthomolecular Aids for dietingMedical Hypotheses, 1982